Shanghai, China · Founded 2015 · Privately Held (backing)
Developer of health assessment and disease diagnostic reagents and microchips, designed for modern biotechnological solutions. HealthCode Bio is based in Shanghai, China and was founded in 2015. Its last reported valuation was $418 million in May 2022.
Last reported valuation
$417.9M
Oct 2026
Priced at
—
Total raised
—
Last round
—
Cap table — not yet on record
HealthCode Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of HealthCode Bio with a free account
·Watch HealthCode Bio: the Monday email on marks, rounds and moves
